Viral News

ORS Drink Ban: Delhi HC Pauses Ban, Doctors Point Out Harmful Health Problems

ORS

A major controversy erupted after the Delhi High Court stayed the ban on ORS (Oral Rehydration Solution) drinks. Hyderabad-based paediatrician Dr Sivaranjani Santosh called it a “national shame”. In a viral video, the doctor criticised the decision, saying that such actions would attract heavy penalties in the US but are being tolerated in India. She warned that allowing the disposal of such drinks poses a serious risk to child health and public safety.

However, the FSSAI later denied these claims, stating that it never permitted the sale or disposal of ORSL stocks. Despite the clarification, outrage continues as doctors warn that such drinks endanger dehydrated children and mislead consumers.

Problems with ORS Drinks

High Sugar Levels

Many so-called “ORS” drinks contain over 120 grams of sugar per litre, far above the WHO-recommended 13.5 grams of dextrose per litre. Such high sugar content can worsen dehydration, raise blood sugar levels, and cause dangerous electrolyte imbalances in children.

Low Electrolyte Content

These drinks often lack adequate 2.6 grams of sodium chloride, 1.5 grams of potassium chloride, and 2.9 grams of sodium citrate per litre, making them ineffective for rehydration. Instead of replenishing lost salts, they simply add sweetness without medical benefit.

Misleading Labels

By branding these beverages as “ORS”, companies mislead consumers into believing they are medical-grade products, when in fact, they resemble soft drinks rather than rehydration solutions.

Risk of Complications in Children

Excess sugar (over 120 grams per litre) and poor electrolyte composition (sodium 2.6 g/L, potassium 1.5 g/L, sodium citrate 2.9 g/L) can lead to severe fluid loss, weakness, and even hospitalisation, particularly in young children suffering from diarrhoea.

In India, 13 out of every 100 child deaths are still caused by diarrhoea, so doctors warn that misleading drinks cannot be allowed. The FSSAI order of 14 October needs to be strictly enforced to ensure that only WHO-approved formulations are sold in pharmacies, hospitals, and schools.

Also Read: After India Suspends Indus Waters Treaty, Taliban Moves to Block Pakistan’s Water Flow from Kunar River